Aviva PLC
07 April 2008
News release
7 April 2008
AVIVA TO ENTER IRISH HEALTH INSURANCE MARKET
• Aviva to enter growing Irish health insurance market through
acquisition of VIVAS Health
• Added strength and breadth to its multi-line insurance group in
Ireland
• Strong growth potential through multi-channel distribution
Aviva plc ('Aviva') today announces that its insurance business in Ireland,
Hibernian Group ('Hibernian'), has agreed to acquire 70% of Irish health
insurance business VIVAS Group Ltd ('VIVAS Health'). Allied Irish Banks plc ('
AIB')* will continue to hold the remaining 30% equity, further strengthening AIB
and Hibernian's existing relationship. The value of VIVAS Health's gross assets
at 31 December 2007 was €88.9 million** (£65.4 million#).
Following the completion of this deal Hibernian's operations will span general
insurance, life and pensions and health insurance. The health insurance
products will be distributed through Hibernian and AIB's distribution channels,
and VIVAS Health's direct and non-direct channels.
VIVAS Health was established in 2004 and has approximately a 5%*** share of the
Irish private medical insurance market. It has built a strong reputation as a
dynamic and innovative health insurance provider in the Irish market.
Stuart Purdy, CEO of Hibernian Group, comments: 'This acquisition brings us
significant growth potential by combining our distribution reach and brand
strength with the innovative and competitive VIVAS Health product range. It
will position us as a provider of the full range of life, non-life and
healthcare products, strengthening our role as Ireland's leading multi-line
insurance group.'
Hibernian is the number one provider of general insurance in Ireland and is a
top three provider in the life and pensions market. With approximately 1.2
million customers, Hibernian has been providing insurance products in Ireland
for 100 years.
AIB operates out of over 276 outlets in Ireland. Hibernian currently
distributes life and pensions and motor business through AIB; and health
insurance distribution will further enhance the relationship.
The closing of the transaction, which is subject to regulatory approval, is
expected to take place in the first half of 2008.
-ends-
* Allied Irish Banks Plc will continue to hold its 30% equity in VIVAS Health
through its subsidiary Allied Irish Banks (Holdings and Investments) Limited
** Unaudited Irish GAAP figures per the draft statutory financial statements as
at 31 December 2007
# At a 2007 closing exchange rate of 1.36 Euro/GBP
*** VIVAS Health is a growing business and this figure relates to the end of
2007
- ends -
Enquiries:
Media
Danielle Anthony, senior group media relations manager +44 (0)20 7662 9511
James Murgatroyd/Ed Simpkins, Finsbury +44 (0)20 7251 3801
Analysts
Charles Barrows, investor relations director +44 (0)20 7662 8115
Jessie Burrows, head of investor relations +44 (0)20 7662 2111
Susie Yeoh, investor relations manager +44 (0)20 7662 2117
Notes to editors:
• Aviva, through Hibernian, will acquire 70% of VIVAS Health from
International Investment and Underwriting (IIU) and VIVA Health's management and
staff.
• Hibernian is one of Ireland's largest and most successful financial
organisations with activities spanning general insurance, risk management,
pensions, life assurance and personal financial services.
• Hibernian's full year results for the year ended 31 December 2007
produced an operating profit of €352.9m (2006: €188.9m).
• Aviva is the leading provider of life and pensions to Europe with
substantial positions in other markets around the world, making it the world's
fifth largest insurance group based on gross worldwide premiums at 31 December
2006.
• Aviva's principal business activities are long-term savings, fund
management and general insurance, with worldwide total sales of £49.2 billion
and funds under management of £364 billion at 31 December 2007.
• The Aviva media centre at www.aviva.com/media includes image, company
and product information and a news release archive.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.